The purpose of the study is to gain a holistic view of the active plasma medicine projects implemented in several countries. The report contains the analysis of various such as recent trends, technological advancements, reimbursement scenario, and international level initiatives across the globe influencing the adoption of plasma medicine.

1. 1
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/
March 2022
Plasma Medicine
Market: Strategies
and
Implementation
Table of Content

2. 2
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-
growth applications, deeply segmented granular country-level market data and other important market
parameters useful in the strategic decision making for senior management. BIS Research provides multi-client
reports, company profiles, databases, and custom research services.
Copyright © 2022 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third
party.

3. 3
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
Table of Content
Scope of the Study .............................................................................9
1. Strategies and Implementation ..................................................11
1.1 Industry Overview............................................................................................12
1.1.1 Plasma Medicine: Overview .......................................................................12
1.1.2 Timeline: Evolution of the Plasma Medicine.............................................12
1.2 An Insight on Plasma Medicine......................................................................13
1.3 Applications .....................................................................................................13
1.3.1 Therapeutic Applications............................................................................14
1.3.2 Biological Decontamination .......................................................................15
1.4 Risk Estimation................................................................................................16
1.5 Basic Cell Biology of Plasma-Supplied Wound Healing ..............................17
1.6 Challenges and Perspectives of Plasma Medicine.......................................18
1.7 Strategies for Implementation of Plasma Medicine (by Region) .................19
1.7.1 North America..............................................................................................19
1.7.1.1 U.S..................................................................................................................... 19
1.7.1.1.1 U.S. Medical Innovations ......................................................................................... 19
1.7.1.1.2 Products Offered by the Company........................................................................... 20
1.7.1.1.3 The Canady Cold Plasma Procedure ...................................................................... 22
1.7.2 Europe..........................................................................................................22
1.7.2.1 Netherlands ....................................................................................................... 22
1.7.2.1.1 Plasmacure .............................................................................................................. 22
1.7.2.1.2 Product Offered by the Company ............................................................................ 22
1.7.2.2 Germany............................................................................................................ 24
1.7.2.2.1 neoplas med GmbH................................................................................................. 24
1.7.2.2.1.1 Product Offered by the Company..................................................................... 24
1.7.2.2.1.2 Treatment of Chronic Wounds: Mode of Action of the kINPen MED ............... 26
1.7.2.2.2 terraplasma medical GmbH ..................................................................................... 26

4. 4
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
1.7.2.2.2.1 Product offered by the Company...................................................................... 27
1.7.2.2.3 coldplasmatech GmbH............................................................................................. 28
1.7.2.2.3.1 Product offered by the Company:..................................................................... 28
1.7.2.2.3.2 CPT Treatment ................................................................................................. 29
1.7.2.3 Georgia.............................................................................................................. 29
1.7.2.3.1 Plasma Surgical ....................................................................................................... 29
1.7.2.3.1.1 Product Offered by the Company..................................................................... 29
1.8 SWOT Analysis of Plasma Medicine ..............................................................31
1.8.1 Strengths......................................................................................................32
1.8.2 Weaknesses.................................................................................................32
1.8.3 Opportunities...............................................................................................33
1.8.4 Threats .........................................................................................................33
1.9 The Making of Plasma Medicine.....................................................................33
1.9.1 Europe..........................................................................................................33
1.9.1.1 Germany............................................................................................................ 33
1.9.1.1.1 Trends in German Innovation Policy........................................................................ 33
1.9.1.1.2 Plasma Medication is Becoming More Prominent Method of Treatment................. 34
1.9.1.1.3 Strategic and Organizational Dilemmas and Management Issues: Trust
Formation, Strategy Implementation, and Stakeholder Management .................... 34
1.9.1.1.4 Policy Implications ................................................................................................... 36
1.10 Recent Plasma Therapy News and Information............................................37
1.10.1 As a Potential Treatment for Diabetic Foot Ulcers, Cold Plasma
Ionised Gas Could Also Kill COVID-19 Virus Indoors ..............................37
1.10.2 Cold Plasma against the Coronavirus.......................................................38
1.10.3 Immunotherapy for Melanoma Could Be Improved by Using a Cold
Plasma Patch ...............................................................................................38
1.11 Competitive Benchmarking ............................................................................40
1.11.1 US Medical Innovations ..............................................................................40
1.11.1.1 Company Overview ........................................................................................... 40

5. 5
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
1.11.1.2 Role of US Medical Innovations in the Plasma Medicine Market ...................... 40
1.11.1.3 SWOT Analysis.................................................................................................. 42
1.11.2 Plasmacure ..................................................................................................43
1.11.2.1 Company Overview ........................................................................................... 43
1.11.2.2 Role of Plasmacure in the Plasma Medicine Market ......................................... 43
1.11.2.3 SWOT Analysis.................................................................................................. 44
1.11.3 neoplas med GmbH.....................................................................................45
1.11.3.1 Company Overview ........................................................................................... 45
1.11.3.2 Role of neoplas med GmbH in the Plasma Medicine Market ............................ 45
1.11.3.3 SWOT Analysis.................................................................................................. 46
1.11.4 Plasma Surgical...........................................................................................47
1.11.4.1 Company Overview ........................................................................................... 47
1.11.4.2 Role of Plasma Surgical in the Plasma Medicine Market .................................. 47
1.11.4.3 SWOT Analysis.................................................................................................. 48
1.11.5 Coldplasmatech GmbH...............................................................................49
1.11.5.1 Company Overview ........................................................................................... 49
1.11.5.2 Role of coldplasmatech GmbH in the Global Plasma Medicine Market ............ 49
1.11.5.3 SWOT Analysis.................................................................................................. 50
1.11.6 terraplasma medical GmbH ........................................................................51
1.11.6.1 Company Overview ........................................................................................... 51
1.11.6.2 Role of terraplasma medical GmbH in the Plasma Medicine Market ................ 51
1.11.6.3 SWOT Analysis.................................................................................................. 52

6. 6
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
List of Figures
Figure 1: Plasma Medicine Market: Segmentation
Figure 2: Fields of Biomedical Applications of Physical Plasma
Figure 3: Important Turning Points in the Evolution of Low-Temperature Plasma Medicine
Figure 4: Basic Concept of Plasma Supported Wound Healing
Figure 5: Departments of the Company
Figure 6: Estimated New Cancers
Figure 7: Effective Components of Cold Plasma
Figure 8: Research Areas of the Product
Figure 9: SWOT Analysis of CAP Technology
Figure 10: US Medical Innovations: Product Portfolio
Figure 11: US Medical Innovations: SWOT Analysis
Figure 12: Plasmacure: Product Portfolio
Figure 13: Plasmacure: SWOT Analysis
Figure 14: neoplas med GmbH: Product Portfolio
Figure 15: neoplas med GmbH: SWOT Analysis
Figure 16: Plasma Surgical: Product Portfolio
Figure 17: Plasma Surgical: SWOT Analysis
Figure 18: Coldplasmatech GmbH: Product Portfolio
Figure 19: Coldplasmatech GmbH: SWOT Analysis
Figure 20: terraplasma medical GmbH: Product Portfolio
Figure 21: terraplasma medical GmbH: SWOT Analysis

7. 7
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More Know More
Know More
Know More

8. 8
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

9. 9
All rights reserved at BIS Research Inc.
P
l
a
s
m
a
M
e
d
i
c
i
n
e
M
a
r
k
e
t
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com